Curevac Nv Stock Alpha and Beta Analysis
| CVAC Stock | USD 4.66 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as CureVac NV. It also helps investors analyze the systematic and unsystematic risks associated with investing in CureVac NV over a specified time horizon. Remember, high CureVac NV's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to CureVac NV's market risk premium analysis include:
Beta 0.27 | Alpha (0.21) | Risk 2.87 | Sharpe Ratio (0.09) | Expected Return (0.25) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. CureVac NV Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. CureVac NV market risk premium is the additional return an investor will receive from holding CureVac NV long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in CureVac NV. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate CureVac NV's performance over market.| α | -0.21 | β | 0.27 |
CureVac NV Fundamentals Vs Peers
Comparing CureVac NV's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze CureVac NV's direct or indirect competition across all of the common fundamentals between CureVac NV and the related equities. This way, we can detect undervalued stocks with similar characteristics as CureVac NV or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of CureVac NV's fundamental indicators could also be used in its relative valuation, which is a method of valuing CureVac NV by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare CureVac NV to competition |
| Fundamentals | CureVac NV | Peer Average |
| Return On Equity | 0.4 | -0.31 |
| Return On Asset | 0.24 | -0.14 |
| Profit Margin | 1.82 % | (1.27) % |
| Operating Margin | 5.73 % | (5.51) % |
| Current Valuation | 599.28 M | 16.62 B |
| Shares Outstanding | 225.17 M | 571.82 M |
| Shares Owned By Insiders | 0.09 % | 10.09 % |
CureVac NV Opportunities
CureVac NV Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | BioNTech Launches Public Exchange Offer for CureVac in 1.25B All-Stock Deal - Pharmaceutical Commerce | 10/23/2025 |
2 | Applying big data sentiment scoring on CureVac N.V. - Quarterly Earnings Report Verified Trade Idea Suggestions - newser.com | 11/13/2025 |
3 | CureVac Sees Large Volume Increase Heres What Happened | 11/26/2025 |
4 | BioNTech Achieves Minimum Condition in CureVac Exchange Offer | 12/03/2025 |
5 | CureVac N.V. Nasdaq Composite Tracks Biotech Momentum | 12/17/2025 |
6 | BioNTech SE Closes the Acquisition of CureVac N.V. | 12/23/2025 |
About CureVac NV Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including CureVac or other stocks. Alpha measures the amount that position in CureVac NV has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 2.59 | 6.13 | 5.51 | 5.79 | Days Of Inventory On Hand | 72.79 | 1.87 | 2.15 | 2.04 |
CureVac NV Upcoming Company Events
As portrayed in its financial statements, the presentation of CureVac NV's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CureVac NV's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of CureVac NV's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of CureVac NV. Please utilize our Beneish M Score to check the likelihood of CureVac NV's management manipulating its earnings.
| 23rd of April 2024 Upcoming Quarterly Report | View | |
| 4th of June 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 23rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with CureVac NV
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
CureVac NV technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.